NCT06647511 Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
| NCT ID | NCT06647511 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Gestational Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-09-12 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2024-09-12 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are: * Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation? * Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers? * Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure? Participants will: * Complete baseline and follow-up in-person appointments; * Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy; * Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.
Eligibility Criteria
Inclusion Criteria: * Pregnant * Refugee, asylum seeking, or asylee as designated by the U.S. Government * Greater than or equal to 18 years of age * Has a personal smartphone Exclusion Criteria: * Unable to provide informed consent * Determined by the PI to be in an extremely vulnerable position and therefore not suited for research participation * Planned move from the New York City (NYC) area within the next 24 months
Contact & Investigator
Gunisha Kaur, MA, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT06647511 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gestational Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06647511 currently recruiting?
Yes, NCT06647511 is actively recruiting participants. Contact the research team at gus2004@med.cornell.edu for enrollment information.
Where is the NCT06647511 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06647511 clinical trial?
NCT06647511 is sponsored by Weill Medical College of Cornell University. The principal investigator is Gunisha Kaur, MA, MD at Weill Medical College of Cornell University. The trial plans to enroll 75 participants.